建立质量改进学习协作组织以改善儿科脓毒症结局
美国儿童医院协会建立了改善儿科脓毒症结局(IPSO)的多中心质量改进学习协作组织,覆盖急诊、ICU、普通病房和血液肿瘤病房。基线脓毒症归因死亡率为3.1%,医院获得性脓毒症发生率为每1000例住院1.3例。
要点
- 基线脓毒症归因死亡率为3.1%,医院获得性脓毒症发生率为每1000例住院1.3例。
- 关键驱动图聚焦感染治疗、脓毒症识别与诊疗、去升级不必要医疗、患者家庭参与和绩效优化。
核心结论
- IPSO协作组织旨在通过协作学习和可靠实施循证干预来改善儿科脓毒症结局。
研究设计与样本
- 通过两次面对面会议和多次电话会议回顾治疗指南和文献,并定义和分析基线脓毒症归因死亡率和医院获得性脓毒症。
主要发现
- 基线脓毒症归因死亡率为3.1%。
- 医院获得性脓毒症的发生率为每1000例住院1.3例。
- 100%的参与团队参与了教育和信息共享活动。
关键数值与推荐
- 关键驱动图的主要驱动因素包括改善感染治疗、脓毒症识别诊断治疗、去升级不必要医疗、患者家庭参与和绩效优化方法。
临床怎么用
- 参与协作的医院可参考关键驱动图的重点领域来设计质量改进干预措施。
- 协作组织通过教育和信息共享活动促进各团队参与。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pediatric sepsis is a major public health problem. Published treatment guidelines and several initiatives have increased adherence with guideline recommendations and have improved patient outcomes, but the gains are modest, and persistent gaps remain. The Children's Hospital Association Improving Pediatric Sepsis Outcomes (IPSO) collaborative seeks to improve sepsis outcomes in pediatric emergency departments, ICUs, general care units, and hematology/oncology units. We developed a multicenter quality improvement learning collaborative of US children's hospitals. We reviewed treatment guidelines and literature through 2 in-person meetings and multiple conference calls. We defined and analyzed baseline sepsis-attributable mortality and hospital-onset sepsis and developed a key driver diagram (KDD) on the basis of treatment guidelines, available evidence, and expert opinion. Fifty-six hospital-based teams are participating in IPSO; 100% of teams are engaged in educational and information-sharing activities. A baseline, sepsis-attributable mortality of 3.1% was determined, and the incidence of hospital-onset sepsis was 1.3 cases per 1000 hospital admissions. A KDD was developed with the aim of reducing both the sepsis-attributable mortality and the incidence of hospital-onset sepsis in children by 25% from baseline by December 2020. To accomplish these aims, the KDD primary drivers focus on improving the following: treatment of infection; recognition, diagnosis, and treatment of sepsis; de-escalation of unnecessary care; engagement of patients and families; and methods to optimize performance. IPSO aims to improve sepsis outcomes through collaborative learning and reliable implementation of evidence-based interventions.
引用
- Larsen GY, Brilli R, Macias CG, et al. Development of a Quality Improvement Learning Collaborative to Improve Pediatric Sepsis Outcomes. Pediatrics. 2020. PMID: 33328337. doi:10.1542/peds.2020-1434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。